ANN ARBOR–Kraig Biocraft Laboratories Inc. (OTC: KBLB), the Ann Arbor-based developer of genetically engineered silkworms that produce silk with the strength of spiderweb fibers, announced the completion and genetic screening of its latest batch of spider silk silkworm eggs.
Those eggs are now ready for shipment to Vietnam to restart commercial production of spider silk. Production at Kraig’s facilities in Vietnam were suspended in March due to the COVID-19 pandemic.
Since then, Kraig’s development center in the United States focused its efforts on improving the performance and genetics of its Dragon Silk strain of recombinant spider silk silkworms. Kraig Labs’ U.S. operations also used this time to scale up its supply of silkworm eggs to allow for a restart of its operations in Vietnam.
“Our teams have done a fantastic job, making significant progress in our genetics, production readiness, and R&D,” said CEO and founder Kim Thompson. “We believe that these silkworm eggs that are now ready for shipment to our factory, represent the future of spider silk production.”
For more information on Kraig’s progress toward super-strong silk fibers for the military and textile markets, visit www.KraigLabs.com/news/